Metagenomic next-generation sequencing (mNGS) for detecting pathogens and antimicrobial resistance genes (ARGs), and guiding antimicrobial therapy in cancer patients from Southwest China.

Published 08/06/2026

Research record: Metagenomic next-generation sequencing (mNGS) for detecting pathogens and antimicrobial resistance genes (ARGs), and guiding antimicrobial therapy in cancer patients from Southwest China.

Published in J Glob Antimicrob Resist; first publication date 2026-08-06. PMID 42562314.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Read the original publication on PubMed

Talk to a Specialist Browse all insights

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-08-06

Updated

2026-10-20

Disclaimer

professional use

References